Aetna’s Sanctions on Medicare Products Lifted

Aetna is able to resume marketing and enrollment for its Medicare products, as the Centers for Medicare & Medicaid Services has lifted its sanctions, according to an Aetna news release.

Advertisement

CMS originally sanctioned Aetna due to improper administration of the Medicare drug benefit in the plan’s national standalone prescription drug plan and its 25 Medicare Advantage prescription drug contracts, according to an April 2010 CMS news release.

Click here to read the full story in Becker’s ASC Review about Aetna and CMS.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.